Development of a Commercial Ready Process for TNG908: A Potent, Selective, and Brain-Penetrant MTA-Cooperative PRMT5 Inhibitor

Penetrant (biochemical)
DOI: 10.1021/acs.oprd.5c00017 Publication Date: 2025-02-20T15:45:12Z